Home > M&A deals 2021 > Merck & Co., Inc. acquires Acceleron Pharma, Inc.
Add-on Acquistion · September 2021

Merck & Co., Inc. acquires Acceleron Pharma, Inc.

On September 30, 2021, Merck & Co., Inc. acquired Acceleron Pharma, Inc. in Massachusetts, United States.

Deal at a glance

AnnouncedSeptember 30, 2021 TypeAdd-on Acquistion TargetAcceleron Pharma, Inc. Buyer Merck & Co., Inc. LocationMassachusetts, United States ValueMembers only

Target company

Acceleron Pharma, Inc.
Massachusetts, United States
-sector
2003founded
Activestatus
View the company profile →

Buyer

Merck & Co., Inc.
Company · 32 deals on record
  • 16th transaction in United States
32deals, all time
0in this sector
2021latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Questions about this deal

Who acquired Acceleron Pharma, Inc.?Merck & Co., Inc. acquired Acceleron Pharma, Inc. on September 30, 2021.

What type of deal was it?It was a add-on acquistion in 2021.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).